0001209191-12-024325.txt : 20120426 0001209191-12-024325.hdr.sgml : 20120426 20120426153826 ACCESSION NUMBER: 0001209191-12-024325 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120425 FILED AS OF DATE: 20120426 DATE AS OF CHANGE: 20120426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 12783322 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 4 1 doc4.xml FORM 4 SUBMISSION X0305 4 2012-04-25 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2012-04-25 4 M 0 4000 15.87 A 636895 D Common Stock 2012-04-25 4 S 0 4000 37.72 D 632895 D Common Stock 13286 I 401(k) Common Stock 300000 I Common Stock held in trust. Stock Option 15.87 2012-04-25 4 M 0 4000 0.00 D 2012-07-21 Common Stock 4000 7314 D Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $37.72 (range $37.28 to $38.03). Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Common stock held in grantor retained annuity trusts. Fully vested. David T. Howton, Attorney-In-Fact 2012-04-26